ISSN: 1935-1232 (P)
Abstract
Antipsychotic Drug Development Continues Along Innovative Paths
Author(s): Peter F. BuckleyIntra-Cellular Therapies, Inc. recently announced the results of a Phase IB/II study of a putative antipsychotic, ITI-007.
Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report
Intra-Cellular Therapies, Inc. recently announced the results of a Phase IB/II study of a putative antipsychotic, ITI-007.